Radiation therapy isn’t just for cancer. In low doses, it can be used to treat non-malignant conditions like osteoarthritis, but many clinicians barely learn about it. As part of Xstrahl’s clinical education program, we invited Dr. Jason Beckta, Radiation Oncologist...
Explore the transformative impact of radiotherapy in skin cancer management, focusing on the three Cs: Cure, Cosmesis, and Convenience. This webinar offers dermatologists and GPs practical insights into radiotherapy practices to optimise patient outcomes for...
Xstrahl, a global leader in the delivery of superficial radiation therapy devices and preclinical radiation research systems, will demonstrate Xstrahl 200, a modern orthovoltage radiotherapy solution for treating superficial lesions, skin cancers, and selective benign conditions. Visit Xstrahl at booth 220 at the ACRO Summit 2025 – The Radiation Oncology Summit located at Planet Hollywood, Las Vegas, NV from March 12-15, 2025.
In this webinar, Dr. Rebecca Oberley-Deegan, from the University of Nebraska, discusses a new technique developed on the SARRP to generate high quality images for measuring orthotopic prostate cancer in mice. This user-led event highlights the work performed and the...
Xstrahl, a global leader in the delivery of superficial and orthovoltage radiation therapy and preclinical radiation research systems, will feature Radiant™ Aura with XBeam treatment planning at the annual meeting of the American Academy of Dermatology (AAD), in Orlando, FL, from March 7-9, 2025 (Booth #2975).
Xstrahl in Action The efficacy and side effects of radiotherapy (RT) depend on parameters like dose and the volume of irradiated tissue. RT induces modulations of the tumor immune microenvironment (TIME) that are dependent on the dose. Low dose RT (LDRT, i.e., single...
While the gold standard for treating non-melanoma skin cancer continues to be Mohs surgery, the number of patients who are good candidates for radiation therapy has been increasing dramatically in recent years, especially in the cohort of patients who are highly...
Xstrahl in Action Studies during the past 9 years suggest that delivering radiation at dose rates exceeding 40 Gy/s, known as “FLASH” radiation therapy, enhances the therapeutic index of radiation therapy (RT) by decreasing normal tissue damage while maintaining tumor...
SmART-XPS is a Monte Carlo based Treatment Planning Software developed and optimised for use on the SARRP platform. This webcast focuses on the intuitive yet advanced irradiation planning capabilities for the Xstrahl SARRP and highlights the roadmap for 2025 of new...
Contact Us